Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117094) titled 'A study comparing the safety and efficacy of 2 drugs namely upadacitinib and methotrexate in patients with atopic dermatitis' on Sept. 7.
Study Type: Interventional
Study Design:
Randomized, Parallel Group Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Open Label
Primary Sponsor: AIIMS New Delhi
Condition:
Health Condition 1: L209- Atopic dermatitis, unspecified
Intervention:
Intervention1: ORAL UPADACITINIB: STARTED AT 15 mg OD FOR 6 MONTHS
Control Intervention...